Characterization of genetic loss-of-function of Fus in zebrafish

被引:18
|
作者
Lebedeva, Svetlana [1 ]
Domingues, Antonio M. de Jesus [1 ]
Butter, Falk [1 ]
Ketting, Rene F. [1 ]
机构
[1] Inst Mol Biol, Mainz, Germany
关键词
CRISPR-Cas9; Danio rerio; Fus; genetic knockout; morpholino; zebrafish; MOTOR-NEURON DEGENERATION; WILD-TYPE; TOXIC GAIN; ALS; PROTEINS; FUS/TLS; BINDING; MUTATIONS; TDP-43; DEFICIENCY;
D O I
10.1080/15476286.2016.1256532
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RNA-binding protein FUS is implicated in transcription, alternative splicing of neuronal genes and DNA repair. Mutations in FUS have been linked to human neurodegenerative diseases such as ALS (amyotrophic lateral sclerosis). We genetically disrupted fus in zebrafish (Danio rerio) using the CRISPR-Cas9 system. The fus knockout animals are fertile and did not show any distinctive phenotype. Mutation of fus induces mild changes in gene expression on the transcriptome and proteome level in the adult brain. We observed a significant influence of genetic background on gene expression and 3UTR usage, which could mask the effects of loss of Fus. Unlike published fus morphants, maternal zygotic fus mutants do not show motoneuronal degeneration and exhibit normal locomotor activity.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [31] ALS/FTD-Linked Mutation in FUS Suppresses Infra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS
    Lopez-Erauskin, Jone
    Tadokoro, Takahiro
    Baughn, Michael W.
    Myers, Brian
    McAlonis-Downes, Melissa
    Chillon-Marinas, Carlos
    Asiaban, Joshua N.
    Artates, Jonathan
    Bui, Anh T.
    Vetto, Anne P.
    Lee, Sandra K.
    Le, Ai Vy
    Sun, Ying
    Jambeau, Melanie
    Boubaker, Jihane
    Swing, Deborah
    Qiu, Jinsong
    Hicks, Geoffrey G.
    Ouyang, Zhengyu
    Fu, Xiang-Dong
    Tessarollo, Lino
    Ling, Shuo-Chien
    Parone, Philippe A.
    Shaw, Christopher E.
    Marsala, Martin
    lagier-Tourenne, ClotilDe
    Cleveland, Don W.
    Da Cruz, Sandrine
    NEURON, 2018, 100 (04) : 816 - +
  • [32] Evaluating drug targets through human loss-of-function genetic variation
    Eric Vallabh Minikel
    Konrad J. Karczewski
    Hilary C. Martin
    Beryl B. Cummings
    Nicola Whiffin
    Daniel Rhodes
    Jessica Alföldi
    Richard C. Trembath
    David A. van Heel
    Mark J. Daly
    Stuart L. Schreiber
    Daniel G. MacArthur
    Nature, 2020, 581 : 459 - 464
  • [33] Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer
    J Mullenders
    R Bernards
    Oncogene, 2009, 28 : 4409 - 4420
  • [34] Predicting Loss-of-Function Impact of Genetic Mutations: A Machine Learning Approach
    Kaur, Arshmeet
    Sarmadi, Morteza
    ADVANCES IN ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2024, 4 (01): : 2091 - 2102
  • [35] Loss-of-function genetic screens as a tool to improve the diagnosis and treatment of cancer
    Mullenders, J.
    Bernards, R.
    ONCOGENE, 2009, 28 (50) : 4409 - 4420
  • [36] Evaluating drug targets through human loss-of-function genetic variation
    Minikel, Eric Vallabh
    Karczewski, Konrad J.
    Martin, Hilary C.
    Cummings, Beryl B.
    Whiffin, Nicola
    Rhodes, Daniel
    Alfoldi, Jessica
    Trembath, Richard C.
    van Heel, David A.
    Daly, Mark J.
    Schreiber, Stuart L.
    MacArthur, Daniel G.
    NATURE, 2020, 581 (7809) : 459 - +
  • [37] Loss-of-function mutations in RET
    Chakravarti, A
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (06) : 705 - 705
  • [38] Laminin: loss-of-function studies
    Yao, Yao
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (06) : 1095 - 1115
  • [40] Laminin: loss-of-function studies
    Yao Yao
    Cellular and Molecular Life Sciences, 2017, 74 : 1095 - 1115